Bailey, Kristian M <br/><br/>
Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.  [electronic resource] 

 -  Circulation. Cardiovascular genetics  Jun 2010 
 - 276-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1942-3268 
<br/><br/><label>Standard No.: </label>10.1161/CIRCGENETICS.109.898502  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Aged<br/>Cholesterol, LDL--blood<br/>Cytochrome P-450 CYP3A--genetics<br/>Cytochrome P-450 Enzyme System--genetics<br/>Female<br/>Fluorobenzenes--therapeutic use<br/>Genotype<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Liver-Specific Organic Anion Transporter 1<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Neoplasm Proteins--genetics<br/>Odds Ratio<br/>Organic Anion Transporters--genetics<br/>Polymorphism, Single Nucleotide<br/>Pyrimidines--therapeutic use<br/>Regression Analysis<br/>Rosuvastatin Calcium<br/>Simvastatin--therapeutic use<br/>Sulfonamides--therapeutic use